Where can I get more information about KESIMPTA®▼ (ofatumumab)?
More information
Summary of Product Characteristics (SmPC) for Kesimpta
Patient Information Leaflet (PIL) for Kesimpta
These links will take you to the electronic medicines compendium (emc) website, which is a non-Novartis website.
UK | January 2025 | 444899
Reporting side-effects
If you get side-effects with any medication you are taking, talk to your doctor, pharmacist or nurse. This includes any possible side-effects not listed in the information leaflet that comes in the pack. ▼ The medicine referred to in this material is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side-effects you may get. Please see www.mhra.gov.uk/yellowcard. for instructions on how to report side-effects.